Healthcare Services Group, Inc.

NASDAQ:HCSG

Medical - Care Facilities

Healthcare
$25.10 +1.74%

+$0.39 today

Market cap
$1.69B
Beta
0.83
P/E (TTM)
23.4
EPS (TTM)
$0.97
52W Low $12.66High $24.39

Volume 0.62M

Average 0.69M

HCSG Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

Healthcare Services Group, Inc.NASDAQ: HCSG

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow grows, but more slowly than its trailing trend

Q1 FY2026 free cash flow of $42.33M rose 64.3% year over year, behind the +98.5% change in trailing-twelve-month free cash flow. Sequentially, it rose 164.5% from the prior quarter.

Context

  • Free cash flow amounted to 7.6% of revenue in FY2025, up 6.1 pp from a year earlier.
  • Free cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +64.3% toward the trailing-twelve-month pace of +98.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$42.33M+164.5% QoQ
Last fiscal yearDec 2025
$139.15M+468.7% YoY
LTMMar 2026
$155.72M+98.5% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+64.3%——
1 year+468.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
139.15M USD
Year-over-year change
+468.7%
4-year CAGR
+45.1%

Free Cash Flow vs competitors

How HCSG compares with its peers on the latest reported figures

  • HCSG's LTM Mar 2026 free cash flow of $155.72M is the 3rd largest of the 11 companies compared; the peer median is $58.31M.
  • Its year-over-year change of +98.5% is the 3rd highest of 11, against a peer median of +27.3%.
  • Free cash flow amounts to 8.4% of revenue for HCSG, versus a peer median of 9.0%.
HCSG Competitors Peer median
Free Cash Flow for HCSG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ZBIOZenas BioPharma, Inc.LTM Mar 2026$210.48M +52.8%+36.4%—
AHCOAdaptHealth Corp.LTM Apr 2026$191.95M -30.1%—6.7%
HCSGHealthcare Services Group, Inc.LTM Mar 2026$155.72M +98.5%—8.4%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$131.64M +39.2%+21.5%16.7%
CNMDCONMED CorporationLTM Mar 2026$123.71M -24.8%+135.3%9.0%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$119.95M +35.4%—143.3%
SEMSelect Medical Holdings CorporationLTM Mar 2026$117.24M -67.4%+59.4%2.1%
NVAXNovavax, Inc.LTM Mar 2026$97.17M -51.0%-21.1%16.3%
USPHU.S. Physical Therapy, Inc.LTM Mar 2026$66.87M +19.2%+6.6%9.2%
NEOGNeogen CorporationLTM Aug 2026$49.75M +1677.8%—5.6%
PNTGThe Pennant Group, Inc.LTM Mar 2026$47.34M +443.2%—4.6%
Peer median (excluding HCSG) $58.31M+27.3%+29.0%9.0%

Competitors are the stored peer set for HCSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income45.86M34.63M38.39M39.47M59.06M
Depreciation & Amortization14.67M15.32M14.34M14.59M17.07M
Deferred Income Tax3.07M5.05M(4.82M)(2.94M)19.2M
Stock-Based Compensation8.83M9.21M8.99M9.17M12.01M
Change in Working Capital(43.15M)(114.77M)(44.16M)(70.19M)(40.55M)
Accounts Receivables(37.19M)(78.71M)(74.56M)(61.81M)5.23M
Inventory5.6M4.85M2.69M1.73M(48K)
Accounts Payables10.24M(13.75M)7.43M(9.74M)(12.06M)
Other Working Capital(21.81M)(27.17M)20.28M(374K)(33.66M)
Other Non-Cash Items7.83M42.4M30.77M40.72M78.18M
Operating Cash Flow37.11M(8.17M)43.5M30.8M144.97M
Capital Expenditures(5.69M)(5.21M)(5.41M)(6.34M)(5.82M)
Acquisitions (Net)(23.88M)(114K)0(2.75M)(7.15M)
Purchases of Investments(20.34M)(2.88M)0(52.09M)(21.34M)
Sales of Investments26.7M10.39M1.99M67.01M23.21M
Other Investing Activities211K393K121K211K105K
Investing Cash Flow(22.99M)2.58M(3.29M)6.05M(11M)
Debt Repayment025M0(25M)0
Common Stock Issued92K106K000
Common Stock Repurchased(21.54M)0(11.28M)(5.02M)(61.59M)
Dividends Paid(62.23M)(63.37M)000
Other Financing Activities1.02M(661K)(871K)(1.03M)(1.74M)
Financing Cash Flow(82.65M)(38.93M)(12.15M)(31.05M)(63.33M)
Effect of Forex Changes00000
Net Change in Cash(68.54M)(44.52M)28.05M5.8M70.64M
Free Cash Flow31.42M(13.38M)38.09M24.47M139.15M

Healthcare Services Group, Inc.

NASDAQ:HCSG

Intrinsic Alpha fair value

Locked

Current Price

$25.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.